Filing Details
- Accession Number:
- 0001079973-19-000277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-07 17:38:06
- Reporting Period:
- 2019-04-22
- Accepted Time:
- 2019-05-07 17:38:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1516077 | Edward Clarence Smith | 1845 County Road #214 St. Augustine FL 32084 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-22 | 12,500 | $0.75 | 6,086,101 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-22 | 53,333 | $0.08 | 6,139,434 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-23 | 20,390 | $0.08 | 6,159,824 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-23 | 29,610 | $0.08 | 6,189,434 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-23 | 60,294 | $0.09 | 6,249,728 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-25 | 34,600 | $0.08 | 6,284,328 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2019-04-29 | 41,303 | $0.09 | 6,325,631 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 61,353,833 | Direct | |
Common Stock | 0 | Indirect | See footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $0.09 | 2023-11-08 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.06 | 2021-08-31 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.05 | 2020-12-31 | 5,000,000 | 5,000,000 | Direct | |
Common Stock | Stock Option | $0.08 | 2019-12-31 | 5,000,000 | 5,000,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-11-08 | 5,000,000 | 5,000,000 | Direct |
2021-08-31 | 5,000,000 | 5,000,000 | Direct |
2020-12-31 | 5,000,000 | 5,000,000 | Direct |
2019-12-31 | 5,000,000 | 5,000,000 | Direct |
Footnotes
- Shares held by the Clarence E. Smith Trust and purchased on the open market.
- Shares held by Mr. Smith's retirement account.
- Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
- Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.